The Role of DLLs in Cancer: A Novel Therapeutic Target
作者： Meng-Xi Xiu , Yuan-Meng Liu , Bo-hai Kuang
DOI: 10.2147/OTT.S244860
关键词:
摘要: Delta-like ligands (DLLs) control Notch signaling. DLL1, DLL3 and DLL4 are frequently deregulated in cancer influence tumor growth, the vasculature immunity, which play different roles progression. DLLs have attracted intense research interest as anti-cancer therapeutics. In this review, we discuss role of summarize emerging DLL-relevant targeting methods to aid future studies.
sci-hub.st 参考文章(194)
Youguang Pu, Fangfang Zhao, Haiyan Wang, Shanbao Cai, MiR-34a-5p promotes multi-chemoresistance of osteosarcoma through down-regulation of the DLL1 gene. Scientific Reports. ,vol. 7, pp. 44218- 44218 ,(2017) , 10.1038/SREP44218
Alexandre Trindade, Dusan Djokovic, Joana Gigante, Liliana Mendonça, António Duarte, None, Endothelial Dll4 overexpression reduces vascular response and inhibits tumor growth and metastasization in vivo. BMC Cancer. ,vol. 17, pp. 189- 189 ,(2017) , 10.1186/S12885-017-3171-2
Chen Zhang, Long Hai, Meng Zhu, Shengping Yu, Tao Li, Yu Lin, Bo Liu, Xingchen Zhou, Lei Chen, Pengfei Zhao, Hua Zhou, Yubao Huang, Kai Zhang, Bingcheng Ren, Xuejun Yang, Actin cytoskeleton regulator Arp2/3 complex is required for DLL1 activating Notch1 signaling to maintain the stem cell phenotype of glioma initiating cells Oncotarget. ,vol. 8, pp. 33353- 33364 ,(2017) , 10.18632/ONCOTARGET.16495
Chern Ein Oon, Esther Bridges, Helen Sheldon, Richard C.A. Sainson, Adrian Jubb, Helen Turley, Russell Leek, Francesca Buffa, Adrian L. Harris, Ji-Liang Li, Role of Delta-like 4 in Jagged1-induced tumour angiogenesis and tumour growth. Oncotarget. ,vol. 8, pp. 40115- 40131 ,(2017) , 10.18632/ONCOTARGET.16969
Sai Kiran Sharma, Jacob Pourat, Dalya Abdel-Atti, Sean D. Carlin, Alessandra Piersigilli, Alexander J. Bankovich, Eric E. Gardner, Omar Hamdy, Kumiko Isse, Sheila Bheddah, Joseph Sandoval, Kristen M. Cunanan, Eric B. Johansen, Viola Allaj, Vikram Sisodiya, David Liu, Brian M. Zeglis, Charles M. Rudin, Scott J. Dylla, John T. Poirier, Jason S. Lewis, Noninvasive Interrogation of DLL3 Expression in Metastatic Small Cell Lung Cancer Cancer Research. ,vol. 77, pp. 3931- 3941 ,(2017) , 10.1158/0008-5472.CAN-17-0299
P. Bettinsoli, G. Ferrari-Toninelli, S. A. Bonini, C. Prandelli, M. Memo, Notch ligand Delta-like 1 as a novel molecular target in childhood neuroblastoma. BMC Cancer. ,vol. 17, pp. 352- 352 ,(2017) , 10.1186/S12885-017-3340-3
Brian W Wong, Elke Marsch, Lucas Treps, Myriam Baes, Peter Carmeliet, Endothelial cell metabolism in health and disease: impact of hypoxia The EMBO Journal. ,vol. 36, pp. 2187- 2203 ,(2017) , 10.15252/EMBJ.201696150
Zaishun Jin, Tao Zhan, Jing Tao, Biao Xu, Huizhe Zheng, Yongxia Cheng, Bin Yan, Hongwei Wang, Guoqiang Lu, Ying Lin, Sufen Guo, MicroRNA-34a induces transdifferentiation of glioma stem cells into vascular endothelial cells by targeting Notch pathway. Bioscience, Biotechnology, and Biochemistry. ,vol. 81, pp. 1899- 1907 ,(2017) , 10.1080/09168451.2017.1364965
Robert J. Cardnell, Lerong Li, Triparna Sen, Rasha Bara, Pan Tong, Junya Fujimoto, Abbie S. Ireland, Matthew R. Guthrie, Sheila Bheddah, Upasana Banerjee, Nene N. Kalu, You-Hong Fan, Scott J. Dylla, Faye M. Johnson, Ignacio I. Wistuba, Trudy G. Oliver, John V. Heymach, Bonnie S. Glisson, Jing Wang, Lauren A. Byers, Protein expression of TTF1 and cMYC define distinct molecular subgroups of small cell lung cancer with unique vulnerabilities to aurora kinase inhibition, DLL3 targeting, and other targeted therapies Oncotarget. ,vol. 8, pp. 73419- 73432 ,(2017) , 10.18632/ONCOTARGET.20621
Shijing Wang, Rihong Zhou, Fumou Sun, Renjie Li, Min Wang, Min Wu, The two novel DLL4-targeting antibody-drug conjugates MvM03 and MGD03 show potent anti-tumour activity in breast cancer xenograft models Cancer Letters. ,vol. 409, pp. 125- 136 ,(2017) , 10.1016/J.CANLET.2017.09.004